OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Does vitamin D protect or treat Parkinson’s disease? A narrative review
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Hend Mostafa Selim, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 1, pp. 33-40
Open Access | Times Cited: 12

Showing 12 citing articles:

Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102233-102233
Closed Access | Times Cited: 17

The classical and non-classical axes of renin-angiotensin system in Parkinson disease: The bright and dark side of the moon
Hayder M. Al‐kuraishy, Sadiq M. Al‐Hamash, Majid S. Jabir, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102200-102200
Closed Access | Times Cited: 10

The conceivable role of prolactin hormone in Parkinson disease: The same goal but with different ways
Haydar M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102075-102075
Closed Access | Times Cited: 21

The Anti-Inflammatory Roles of Vitamin D for Improving Human Health
Ayşen Kutan Fenercioğlu
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 13514-13525
Open Access | Times Cited: 7

Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet
Manal M. Khowdiary, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European Journal of Pharmacology (2025), pp. 177419-177419
Open Access

Glutamatergic dysfunction in neurodegenerative diseases focusing on Parkinson's disease: Role of glutamate modulators
Najlaa H. Almohmadi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025), pp. 111349-111349
Open Access

Dopaminergic system and neurons: role in multiple neurological diseases
Heng Chen, Jieshu Li, Zhixing Huang, et al.
Neuropharmacology (2024) Vol. 260, pp. 110133-110133
Closed Access | Times Cited: 3

Blunted Melatonin Circadian Rhythm in Parkinson’s Disease: Express Bewilderment
Areej Turkistani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Neurotoxicity Research (2024) Vol. 42, Iss. 5
Closed Access | Times Cited: 2

Retinoic acid in Parkinson's disease: Molecular insights, therapeutic advances, and future prospects
Ashutosh Pareek, R. L. Singhal, Aaushi Pareek, et al.
Life Sciences (2024) Vol. 355, pp. 123010-123010
Open Access | Times Cited: 2

The neuroprotective effect of vitamin D in Parkinson's disease: association or causation
Amin A. Hafiz
Nutritional Neuroscience (2023) Vol. 27, Iss. 8, pp. 870-886
Closed Access | Times Cited: 6

Addressing vitamin D deficiency through nutritional strategies
Tori Trachtenberg, Danik Martirosyan
Bioactive Compounds in Health and Disease - Online ISSN 2574-0334 Print ISSN 2769-2426 (2024) Vol. 7, Iss. 6, pp. 289-301
Open Access

Page 1

Scroll to top